Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Nanocovax / Nanogen Biopharma
NCT04922788: Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19	Active, not recruiting	3	13000	RoW	Nanocovax, Placebo	Nanogen Pharmaceutical Biotechnology Joint Stock Company	SARS-CoV-2 Infection, COVID-19	12/22	12/22
NCT04683484: A Clinical Trial to Assess the Safety and Immunogenicity of Nanocovax in Heathy Volunteers	Recruiting	1/2	620	RoW	Nanocovax, Placebo	Nanogen Pharmaceutical Biotechnology Joint Stock Company	COVID-19	06/21	08/21